You can expand the reach of your research and motivate more people to join your study by enabling them to learn about themselves through the 23andMe experience.
You win. Participants win. Science wins.
Every participant will receive 60+ personalized genetic reports covering health, traits and ancestry.
If the participant is starting a family, they can find out if they are a carrier for an inherited condition.
Sickle Cell Anemia
Hereditary Hearing Loss
What DNA says about a participant’s family history.
Maternal & Paternal Lineage
Helping participants make more informed choices about diet and exercise.
Alcohol Flush Reaction
What makes each participant unique, from food preferences to physical features.
Sweet vs. Salty
|ARSACS||SACS||1 Variant||French Canadian|
|Agenesis of the Corpus Callosum with Peripheral Neuropathy||SLC12A6||1 Variant||French Canadian|
|Autosomal Recessive Polycystic Kidney Disease||PKHD1||3 Variants||N/A|
|Beta Thalassemia and Related Hemoglobinopathies||HBB||10 Variants||Cypriot, Greek, Italian, Sardinian|
|Bloom Syndrome||BLM||1 Variant||Ashkenazi Jewish|
|Congenital Disorder of Glycosylation Type 1a (PMM2-CDG)||PMM2||2 Variants||Danish|
|Cystic Fibrosis||CFTR||28 Variants||European, Hispanic/Latino, Ashkenazi Jewish|
|D-Bifunctional Protein Deficiency||HSD17B4||2 Variants||N/A|
|Dihydrolipoamide Dehydrogenase Deficiency||DLD||1 Variant||Ashkenazi Jewish|
|Familial Dysautonomia||IKBKAP||1 Variant||Ashkenazi Jewish|
|Fanconi Anemia Group C||FANCC||3 Variants||Ashkenazi Jewish|
|GRACILE Syndrome||BCS1L||1 Variant||Finnish|
|Glycogen Storage Disease Type Ia||G6PC||1 Variant||Ashkenazi Jewish|
|Glycogen Storage Disease Type Ib||SLC37A4||2 Variants||N/A|
|Hereditary Fructose Intolerance||ALDOB||3 Variants||European|
|Leigh Syndrome, French Canadian Type||LRPPRC||1 Variant||French Canadian|
|Limb-Girdle Muscular Dystrophy Type 2D||SGCA||1 Variant||Finnish|
|Limb-Girdle Muscular Dystrophy Type 2E||SGCB||1 Variant||Southern Indiana Amish|
|Limb-Girdle Muscular Dystrophy Type 2I||FKRP||1 Variant||European|
|MCAD Deficiency||ACADM||3 Variants||Northern European|
|Maple Syrup Urine Disease Type 1B||BCKDHB||2 Variants||Ashkenazi Jewish|
|Neuronal Ceroid Lipofuscinosis (CLN5-Related)||CLN5||1 Variant||Finnish|
|Neuronal Ceroid Lipofuscinosis (PPT1-Related)||PPT1||3 Variants||Finnish|
|Niemann-Pick Disease Type A||SMPD1||3 Variants||Ashkenazi Jewish|
|Nijmegen Breakage Syndrome||NBN||1 Variant||Eastern European|
|Nonsyndromic Hearing Loss and Deafness, DFNB1 (GJB2-Related)||GJB2||2 Variants||Ashkenazi Jewish, European|
|Pendred Syndrome and DFNB4 Hearing Loss||SLC26A4||6 Variants||N/A|
|Primary Hyperoxaluria Type 2||GRHPR||1 Variant||European|
|Rhizomelic Chondrodysplasia Punctata Type 1||PEX7||1 Variant||N/A|
|Sickle Cell Anemia||HBB||1 Variant||African|
|Sjögren-Larsson Syndrome||ALDH3A2||1 Variant||Swedish|
|Tay-Sachs Disease||HEXA||4 Variants||Ashkenazi Jewish, Cajun|
|Tyrosinemia Type I||FAH||4 Variants||French Canadian, Finnish|
|Usher Syndrome Type 1F||PCDH15||1 Variant||Ashkenazi Jewish|
|Usher Syndrome Type 3A||CLRN1||1 Variant||Ashkenazi Jewish|
|Zellweger Syndrome Spectrum (PEX1-Related)||PEX1||1 Variant||N/A|
*Our tests can be used to determine carrier status in adults from saliva collected using an FDA-cleared collection device (Oragene·DX model OGD-500.001), but cannot determine if you have two copies of the genetic variant. The tests are not intended to diagnose a disease, or tell you anything about your risk for developing a disease in the future. On their own, carrier status tests are not intended to tell you anything about the health of your fetus, or your newborn child's risk of developing a particular disease later in life.
Asparagus Odor Detection
Back Hair (available for men only)
Bald Spot (available for men only)
Bitter Taste Perception
Finger Length Ratio
Light or Dark Hair
Male Hair Loss (available for men only)
Newborn Hair Amount
Photic Sneeze Reflex
Sweet Taste Preference
Toe Length Ratio
A simple saliva sample collected at your research lab or in the privacy of the research participant’s home is all that is needed. There are no needles and no blood. Just spit and ship the vial back to our labs.
We can ship the DNA kits to you, or to research participants’ home directly, which enables you to recruit locally, nationally or globally.
*Our tests can be used to determine carrier status in adults from saliva collected using an FDA-cleared collection device (Oragene·DX model OGD-500.001), but cannot determine if you have two copies of the genetic variant. Each test is most relevant for people of certain ethnicities. The tests are not intended to diagnose a disease, or tell you anything about your risk for developing a disease in the future. On their own, carrier status tests are not intended to tell you anything about the health of your fetus, or your newborn child's risk of developing a particular disease later in life.
** The Cystic Fibrosis carrier status test is indicated for the detection of 28 variants in the CFTR gene and is most relevant for people of Ashkenazi Jewish, European, and Hispanic/Latino descent. The Sickle Cell Anemia carrier status test is indicated for the detection of the HbS variant in the HBB gene and is most relevant for people of African descent. The carrier status tests related to hereditary hearing loss consist of two tests – one indicated for the detection of two variants in the GJB2 gene which is most relevant for people of Ashkenazi Jewish and European descent, and one indicated for the detection of six variants in the SLC26A4 gene.